Thursday, September 24News That Matters
Shadow

Sanofi Gets Priority U.S. FDA Review for Sutimlimab Product

Sanofi Gets Priority U.S. FDA Review for Sutimlimab Product

French healthcare company Sanofi said on Thursday that the U.S. Food & Drug Administration (FDA) regulator had granted a priority review for Sanofi’s sutimlimab product, which treats hemolysis in adults suffering from cold agglutinin disease.

Read More…



Leave a Reply

Your email address will not be published. Required fields are marked *